Skip to content
Search

Latest Stories

BD Rowa unveils next-generation smart dispensing robot with sustainable design

The first installations of the new BD Rowa Smart are set to begin in pharmacies across the UK and Ireland in the first half of 2025

​The next generation of BD Rowa Smart launched

The latest BD Rowa™ Smart introduces a more intuitive user interface.

Photo credit: BD Rowa

Leading medical technology company BD Rowa has announced the launch of the next generation of its smart dispensing robot, offering enhanced convenience with a sustainable design.

Currently in its final development phase, the latest BD Rowa™ Smart introduces a more intuitive user interface designed to streamline operations and enhance the user experience.


According to the company, the new BD Rowa™ Smart incorporates natural materials such as glass, wood, and recycled aluminium.

It is manufactured in a climate-conscious environment powered by solar energy and delivered in reusable packaging, reinforcing BD Rowa’s commitment to sustainability.

“Our machines have been quietly evolving over the years. While the improvements may not always be visible at first glance, we are constantly enhancing performance, reliability, and security,” said Dr Torben Schüttfort, managing director at BD Rowa.

“With the next generation of BD Rowa Smart, we are bringing all these upgrades together in a sleek, modern package.”

Additionally, the new Smart models come pre-equipped with upgraded operating systems and hardware, enabling a seamless, cost-free transition to the new user interface once launched.

Dr. Schüttfort shared that they have developed the new interface in collaboration with over 40 pharmacists, and it’s designed to be highly intuitive, making it easy to onboard new staff quickly, with key functions accessible in just a few clicks.

“The software is currently undergoing field testing with customers, and we are actively incorporating their feedback into the final product,” he said.

The BD Rowa™ Smart continues to offer the core benefits, including quick and seamless installation even during active pharmacy operations, significant time savings of up to six hours per day, and an exceptional 99.9%* reliability rating.

The core benefits of the BD Rowa Smart remain unchanged, including fast installation even during active pharmacy operations, significant time savings of up to six hours per day, and an impressive 99.9% reliability rating.

The first installations of the new BD Rowa™ Smart are set to begin in pharmacies across the UK and Ireland in the first half of 2025.

With more than 2,000 BD Rowa™ Smart machines installed worldwide, the company continues to develop innovative technology, services, and solutions that advance both clinical therapy for patients and healthcare processes for providers.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less